oru.sePublikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
A novel purine analogue bearing nitrate ester prevents platelet activation by ROCK activity inhibition
Örebro universitet, Institutionen för medicinska vetenskaper. (Cardiovascular Research Centre)ORCID-id: 0000-0002-5025-9454
Örebro universitet, Institutionen för medicinska vetenskaper. (Cardiovascular Research Centre)ORCID-id: 0000-0002-4589-6440
National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, Athens, Greece.
National Hellenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, Athens, Greece.
Vise andre og tillknytning
2019 (engelsk)Inngår i: European Journal of Pharmacology, ISSN 0014-2999, E-ISSN 1879-0712, Vol. 857, artikkel-id 172428Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Natural purines like ATP, ADP and adenosine have crucial roles in platelet physiology. This knowledge has been significant in drug development and today ADP receptor antagonists are widely used for prevention of thrombotic events following myocardial infarction and ischaemic stroke.

Recent studies have shown that a purine analogue bearing nitrate ester group (denoted MK128) has anti-inflammatory effects probably due to its ability to donate nitric oxide (NO). However, other pharmacological mechanisms may contribute to the observed effect. The aim of the present study was to establish the anti-platelet activity and elucidate the underlying molecular mechanism(s) of the purine analogue MK128.

We found that MK128 reduced aggregation and secretion induced by the thrombin receptor agonist SFLLRN and nearly abolished aggregation and secretion induced by thromboxane A2 (TxA2) and collagen receptor agonists. The inhibition took place despite blockage of the NO/cGMP signalling system. Furthermore, interaction between MK128 and platelet purinergic receptors did not explain the observed inhibition. Instead, we found that MK128 concentration-dependently inhibited Rho-associated kinase (ROCK), which led to decreased ROCK-dependent myosin phosphatase target subunit (MYPT)-1 phosphorylation and suppression of platelet functional responses.

sted, utgiver, år, opplag, sider
Elsevier, 2019. Vol. 857, artikkel-id 172428
Emneord [en]
Nitric oxide, Platelet inhibitor, Purinergic receptors, Rho associated protein kinase, Thromboxane A2
HSV kategori
Identifikatorer
URN: urn:nbn:se:oru:diva-74650DOI: 10.1016/j.ejphar.2019.172428ISI: 000472711200011PubMedID: 31175850Scopus ID: 2-s2.0-85066786586OAI: oai:DiVA.org:oru-74650DiVA, id: diva2:1322030
Forskningsfinansiär
Knowledge Foundation
Merknad

Funding Agency:

Onassis Foundation

Tilgjengelig fra: 2019-06-10 Laget: 2019-06-10 Sist oppdatert: 2019-11-14bibliografisk kontrollert

Open Access i DiVA

Fulltekst mangler i DiVA

Andre lenker

Forlagets fulltekstPubMedScopus

Personposter BETA

Kardeby, CarolineParamel Varghese, GeenaSirsjö, AllanFransén, KarinGrenegård, Magnus

Søk i DiVA

Av forfatter/redaktør
Kardeby, CarolineParamel Varghese, GeenaSirsjö, AllanFransén, KarinGrenegård, Magnus
Av organisasjonen
I samme tidsskrift
European Journal of Pharmacology

Søk utenfor DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 254 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf